Concepedia
Statistics
Publications
18
Citations
993
H-Index
15
Active since
2009
Affiliations
University of Wisconsin–Madison(Current)
Universiti Sains Malaysia
University of Wisconsin Carbone Cancer Center
UPMC Hillman Cancer Center
Wisconsin Institutes for Discovery
Raghava N. Sriramaneni is an author at University of Wisconsin–Madison specializing in medicine, immunology, and oncology.
Publications per year
2009–2023
Development of an In Situ Cancer Vaccine via Combinational Radiation and Bacterial‐Membrane‐Coated Nanoparticles
Ravi B. Patel, Mingzhou Ye, Peter M. Carlson et al. · Advanced Materials · 2019 · 229 citations · Full text
Medicine, Immunology, Oncology +17
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade
Ravi B. Patel, Reinier Hernandez, Peter M. Carlson et al. · Science Translational Medicine · 2021 · 228 citations · Full text
Tumor-Specific Inhibition of <i>In Situ</i> Vaccination by Distant Untreated Tumor Sites
Zachary S. Morris, Emily I. Guy, Lauryn R. Werner et al. · Cancer Immunology Research · 2018 · 79 citations · Full text
Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade
Ying Zhang, Raghava N. Sriramaneni, Paul A. Clark et al. · Nature Communications · 2022 · 78 citations · Full text
Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy
Justin C. Jagodinsky, Won Jong Jin, Amber M. Bates et al. · Theranostics · 2021 · 77 citations · Full text
1–5 of 18